Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 62
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Ann Ig ; 35(4): 379-402, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37184351

RESUMO

Introduction: Communication has a crucial role in public health, because it becomes an essential component of prevention; it is also a proactive tool in health promotion. From a planning perspective, it is appropriate to use communication means that can help the bidirectional communication process, such as face-to-face communication and telephone communication. Materials and methods: In relation to this, the Italian National Institute of Health has developed the "Modello Operativo Comunicativo-Relazionale" (the "Communicative-Relational Operating Model"). It is based on the fundamental skills of the counselling, this gives a protocol to the health professionals that is replicable and organized and it allows health professionals to carry out a telephone communication that is efficient with the user through technical-scientific and communication-relational skills. The goal is to answer in a customized way to the various users' health needs. The Operating Model was created by experts of the National AIDS and Sexually Transmitted Infections Helpline of the Operational Unit of Psycho-Socio-Behavioural Research, Communication, Training, of the Infectious Diseases Department. Later, the Operating Model was proposed to the experts of the Helplines in the National Centre on Addictions and Doping and the National Helpline of the National Centre for Rare Diseases in the National Institute of Health that integrated this method into their telephone approach. Results: The Operating Model illustrated above was applied to several helplines of the National Institute of Health as an example of correct scientific information, updated and customized on sexual transmitted infections, addictions and rare diseases. Conclusions: This article aims to illustrate the Operating Model, the theoretical prerequisites that subtend it and its possible application in the different public health structures that use the telephone for a profes-sional relationship with their users.


Assuntos
Saúde Pública , Doenças Raras , Humanos , Aconselhamento/métodos , Comunicação , Telefone , Itália
2.
Mol Genet Metab ; 129(4): 243-254, 2020 04.
Artigo em Inglês | MEDLINE | ID: mdl-32033911

RESUMO

Undiagnosed rare diseases (URDs) account for a significant portion of the overall rare disease burden, depending upon the country. Hence, URDs represent an unmet medical need. A specific challenge posed by the ensemble of the URD patient cohort is the heterogeneity of its composition; the group, indeed, includes very rare, still unidentified conditions as well as clinical variants of recognized rare diseases. Exact disease recognition requires new approaches that cut across national and institutional boundaries, may need the implementation of methods new to diagnostics, and embrace clinical care and research. To address these issues, the Undiagnosed Diseases Network International (UDNI) was established in 2014, with the major aims of providing diagnoses to patients, implementing additional diagnostic tools, and fostering research on novel diseases, their mechanisms, and their pathways. The UDNI involves centres with internationally recognized expertise, and its scientific resources and know-how aim to fill the knowledge gaps that impede diagnosis, in particularly for ultra-rare diseases. Consequently, the UDNI fosters the translation of research into medical practice, aided by active patient involvement. The goals of the UDNI are to work collaboratively and at an international scale to: 1) provide diagnoses for individuals who have conditions that have eluded diagnosis by clinical experts; 2) gain insights into the etiology and pathogenesis of novel diseases; 3) contribute to standards of diagnosing unsolved patients; and 4) share the results of UDNI research in a timely manner and as broadly as possible.


Assuntos
Saúde Global , Serviços de Informação/organização & administração , Cooperação Internacional , Doenças Raras/diagnóstico , Doenças não Diagnosticadas , Pesquisa Biomédica , Humanos , Doenças Raras/etiologia , Fatores de Tempo
3.
Neurol Sci ; 40(3): 447-456, 2019 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-30539345

RESUMO

OBJECTIVE: Narcolepsy is a lifelong disease, manifesting with excessive daytime sleepiness and cataplexy, arising between childhood and young adulthood. The diagnosis is typically made after a long delay that burdens the disease severity. The aim of the project, promoted by the "Associazione Italiana Narcolettici e Ipersonni" is to develop Red Flags to detect symptoms for early referral, targeting non-sleep medicine specialists, general practitioners, and pediatricians. MATERIALS AND METHODS: A multidisciplinary panel, including patients, public institutions, and representatives of national scientific societies of specialties possibly involved in the diagnostic process of suspected narcolepsy, was convened. The project was accomplished in three phases. Phase 1: Sleep experts shaped clinical pictures of narcolepsy in pediatric and adult patients. On the basis of these pictures, Red Flags were drafted. Phase 2: Representatives of the scientific societies and patients filled in a form to identify barriers to the diagnosis of narcolepsy. Phase 3: The panel produced suggestions for the implementation of Red Flags. RESULTS: Red Flags were produced representing three clinical pictures of narcolepsy in pediatric patients ((1) usual sleep symptoms, (2) unusual sleep symptoms, (3) endocrinological signs) and two in adult patients ((1) usual sleep symptoms, (2) unusual sleep symptoms). Inadequate knowledge of symptoms at onset by medical doctors turned out to be the main reported barrier to diagnosis. CONCLUSIONS: This report will hopefully enhance knowledge and awareness of narcolepsy among non-specialists in sleep medicine in order to reduce the diagnostic delay that burdens patients in Italy. Similar initiatives could be promoted across Europe.


Assuntos
Comunicação Interdisciplinar , Narcolepsia/diagnóstico , Narcolepsia/epidemiologia , Encaminhamento e Consulta/normas , Adulto , Fatores Etários , Criança , Diagnóstico Tardio/estatística & dados numéricos , Diagnóstico Diferencial , Humanos , Itália , Narcolepsia/fisiopatologia , Médicos
4.
Ann Ig ; 30(4): 307-316, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29895048

RESUMO

Until a few decades ago, Rare Diseases were relatively unknown. Their low prevalence made them invisible to public opinion, and were of little concern to researchers and pharmaceutical industries. Rare disease sufferers and their loved ones had become victims of the disease as their implications were overlooked. Consequently, some of these individuals formed associations and embarked on ways to change this situation of neglect they had found themselves, in finally having their rights recognized. These associations have over time gained important roles in planning public health and biomedical research, especially after the introduction of the Human Genome Project. Their active participation and awareness activities have been crucial in establishing reliable Rare Diseases Registries and related Biobanks, essential tools in fully utilizing the data and the new omics technologies derived from the Human Genome Project in the field of Rare Diseases. The founders and members of these associations have a high degree and considerable ability to face the difficulties of life, while also maintaining a positive attitude and a confident vision, best defined as resilience. Not everyone, and not always, is endowed with a resilience capability. However resilience can be improved or reinforced through appropriate training and intervention programs. This review points out specific programs centered mainly on mindfulness.


Assuntos
Pesquisa Biomédica/organização & administração , Doenças Raras , Sociedades/organização & administração , Projeto Genoma Humano , Humanos , Saúde Pública , Sistema de Registros
5.
Endocr Connect ; 12(12)2023 Dec 01.
Artigo em Inglês | MEDLINE | ID: mdl-37902973

RESUMO

Objective: The European Registries for Rare Endocrine Conditions (EuRRECa, eurreb.eu) includes an e-reporting registry (e-REC) used to perform surveillance of conditions within the European Reference Network (ERN) for rare endocrine conditions (Endo-ERN). The aim of this study was to report the experience of e-REC over the 3.5 years since its launch in 2018. Methods: Electronic reporting capturing new encounters of Endo-ERN conditions was performed monthly through a bespoke platform by clinicians registered to participate in e-REC from July 2018 to December 2021. Results: The number of centres reporting on e-REC increased to a total of 61 centres from 22 countries. A median of 29 (range 11, 45) paediatric and 32 (14, 51) adult centres had reported cases monthly. A total of 9715 and 4243 new cases were reported in adults (age ≥18 years) and children, respectively. In children, sex development conditions comprised 40% of all reported conditions and transgender cases were most frequently reported, comprising 58% of sex development conditions. The median number of sex development cases reported per centre per month was 0.6 (0, 38). Amongst adults, pituitary conditions comprised 44% of reported conditions and pituitary adenomas (69% of cases) were most commonly reported. The median number of pituitary cases reported per centre per month was 4 (0.4, 33). Conclusions: e-REC has gained increasing acceptability over the last 3.5 years for capturing brief information on new encounters of rare conditions and shows wide variations in the rate of presentation of these conditions to centres within a reference network. Significance statement Endocrinology includes a very wide range of rare conditions and their occurrence is often difficult to measure. By using an electronic platform that allowed monthly reporting of new clinical encounters of several rare endocrine conditions within a defined network that consisted of several reference centres in Europe, the EuRRECa project shows that a programme of e-surveillance is feasible and acceptable. The data that have been collected by the e-reporting of rare endocrine conditions (e-REC) can allow the continuous monitoring of rare conditions and may be used for clinical benchmarking, designing new studies or recruiting to clinical trials.

6.
Clin Genet ; 78(6): 507-16, 2010 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-20662852

RESUMO

Multiple osteochondroma (MO) is a rare skeletal disease characterized by the formation of multiple benign cartilage-capped bone tumors; in 1-5% of patients, a malignant transformation into peripheral chondrosarcoma may occur. This disorder is characterized by a large spectrum of germline mutations scattered along EXT1/EXT2 genes, the presence of a significant percentage of patients without alterations in EXT genes, and a large phenotypic variability. The molecular basis of MO genetic and clinical heterogeneity, including the causes underlying malignant transformation, is currently unknown. This leads to the lack of appropriate diagnostic/prognostic markers as well as of therapeutic options. Recently, specific microRNAs (miRNAs) were reported to be involved in chondrogenesis and inflammatory cartilage diseases. We therefore hypothesized a role for microRNAs in cartilaginous tumors and investigated microRNA expression in osteochondroma and normal cartilage tissues to evaluate whether they could affect osteochondromas onset and/or clinical manifestations. Our results indicate that miRNAs differentially expressed in MO samples may hamper the molecular signaling responsible for normal differentiation of chondrocytes, contributing to pathogenesis and clinical outcome. Although further studies are needed to validate our observations and to identify targets of miRNAs, this is the first study reporting on miRNA expression in growth plate and its comparison with pathological conditions.


Assuntos
Cartilagem/metabolismo , Exostose Múltipla Hereditária/genética , MicroRNAs/metabolismo , Neoplasias Ósseas/genética , Neoplasias Ósseas/patologia , Cartilagem/patologia , Exostose Múltipla Hereditária/metabolismo , Exostose Múltipla Hereditária/patologia , Perfilação da Expressão Gênica , Humanos
7.
Br J Dermatol ; 162(3): 518-26, 2010 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-19903178

RESUMO

BACKGROUND: Hailey-Hailey disease (HHD) is an autosomal dominant disorder characterized by suprabasal cutaneous cell separation (acantholysis) leading to the development of erosive and oozing skin lesions. While a strong relationship exists between mutations in the gene that encodes the Ca(2+)/Mn(2+)-adenosine triphosphatase ATP2C1 and HHD, we still have little understanding of how these mutations affect manifestations of the disease. OBJECTIVES: This study was designed to determine early signalling events that affect epithelial cell growth and differentiation during HHD development. METHODS: Expression of key regulatory signals important for maintaining skin homeostasis were evaluated by Western blot analysis and by reverse transcriptase-polymerase chain reaction in primary keratinocytes obtained from skin biopsies of patients with HHD. Reactive oxygen species accumulation in primary keratinocytes derived from lesional skin of patients with HHD was assessed by dihydrorhodamine 123 (DHR) assay. RESULTS: HHD-derived keratinocytes showed downregulation of both Notch1 and differential regulation of different p63 isoforms. Itch and p63 are co-expressed in the epidermis and in primary keratinocytes where Itch controls the p63 protein steady-state level. We found that the Itch protein was significantly decreased in HHD-derived keratinocytes whereas the expression of its target, c-Jun, remained unaffected. We also found that HHD-derived keratinocytes undergo oxidative stress, which may explain both Notch1 and Itch downregulation. CONCLUSIONS: Our attempt to explore the molecular mechanism underlying HHD indicates a complex puzzle in which multi-hit combinations of altered signal pathways may explain the wide spectrum of defects in HHD.


Assuntos
ATPases Transportadoras de Cálcio/genética , Estresse Oxidativo/genética , Pênfigo Familiar Benigno/genética , Cálcio , ATPases Transportadoras de Cálcio/metabolismo , Análise Mutacional de DNA , Homeostase/genética , Humanos , Linhagem , Pênfigo Familiar Benigno/metabolismo , Fenótipo , Receptores Notch/genética , Reação em Cadeia da Polimerase Via Transcriptase Reversa/métodos
8.
Cell Mol Biol (Noisy-le-grand) ; 56 Suppl: OL1299-317, 2010 Jun 10.
Artigo em Inglês | MEDLINE | ID: mdl-20937217

RESUMO

Somatic mutations in the genes members of WNT/ß-catenin pathway, especially in CTNNB1 codifying for ß-catenin, have been found to play an important role in hepatocarcinogenesis. The purpose of this work is to characterize alterations of the WNT/ß-catenin signalling pathway, and to study the expression pattern of a panel of microRNAs and proteins potentially involved in the pathogenesis of liver cancer. In this respect, the molecular characterization of the most used liver cancer cell lines HuH6, Hep3B, HepG2, and HLE, could represent a useful tool to identify novel molecular markers for hepatic tumour. A significant modulation of FZD7, NLK, RHOU, SOX17, TCF7L2, TLE1, SLC9A3R1 and WNT10A transcripts was observed in all the four liver cancer cell lines. The analysis of selected microRNAs showed that miR-122a, miR-125a and miR-150 could be suitable candidates to discriminate tumoural versus normal human primary hepatocytes. Finally, Grb-2 protein expression resulted to be increased more than two-fold in liver cancer cell lines in comparison to normal human primary hepatocytes. These advances in the knowledge of molecular mechanisms involved in the pathogenesis of liver cancer may provide new potential biomarkers and molecular targets for the diagnosis and therapy.


Assuntos
Neoplasias Hepáticas/metabolismo , MicroRNAs/metabolismo , Proteoma/metabolismo , Proteínas Wnt/metabolismo , beta Catenina/metabolismo , Linhagem Celular Tumoral , Proteína Adaptadora GRB2/metabolismo , Perfilação da Expressão Gênica , Hepatócitos/metabolismo , Humanos , Transdução de Sinais
9.
Eur J Endocrinol ; 180(1): 89-98, 2019 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-30407922

RESUMO

Objective To identify cross-border international registries for rare endocrine conditions that are led from Europe and to understand the extent of engagement with these registries within a network of reference centres (RCs) for rare endocrine conditions. Methods Database search of international registries and a survey of RCs in the European Reference Network for rare endocrine conditions (Endo-ERN) with an overall response rate of 82%. Results Of the 42 conditions with orphacodes currently covered within Endo-ERN, international registries exist for 32 (76%). Of 27 registries identified in the Orphanet and RD-Connect databases, Endo-ERN RCs were aware of 11 (41%). Of 21 registries identified by the RC, RD-Connect and Orphanet did not have a record of 10 (48%). Of the 29 glucose RCs, the awareness and participation rate in an international registry was highest for rare diabetes at 75 and 56% respectively. Of the 37 sex development RCs, the corresponding rates were highest for disorders of sex development at 70 and 52%. Of the 33 adrenal RCs, the rates were highest for adrenocortical tumours at 68 and 43%. Of the 43 pituitary RCs, the rates were highest for pituitary adenomas at 43 and 29%. Of the 31 genetic tumour RCs, the rates were highest for MEN1 at 26 and 9%. For the remaining conditions, awareness and participation in registries was less than 25%. Conclusion Although there is a need to develop new registries for rare endocrine conditions, there is a more immediate need to improve the awareness and participation in existing registries.


Assuntos
Doenças do Sistema Endócrino , Doenças Raras , Sistema de Registros , Europa (Continente) , Humanos
10.
Community Genet ; 11(5): 295-303, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18493128

RESUMO

BACKGROUND: The Italian external quality assessment scheme in classical cytogenetics was started in 2001 as an activity funded by the National Health System and coordinated by the Italian Public Institute of Health. OBJECTIVES: The aim of our work is to present data from the first 4 years of activity, 2001-2004. METHODS: Italian cytogenetics public laboratories were enrolled on a voluntary basis, and this nationwide program covered prenatal, postnatal and oncological diagnosis. The scheme is annual and retrospective; a panel of experts reviewed the quality of images and reports in order to assess technical, analytical and interpretative performance. RESULTS: Over the 4-year period, the number of participating laboratories increased: from 36 in 2001, 46 in 2002, 49 in 2003 to 51 in 2004. The overall technical performance was satisfactory. Inadequacy or lack of information in reporting was the most frequent analytical inaccuracy identified in all parts of the scheme. However, the percentage of complete reports increased significantly during the period: by 36% in postnatal diagnosis between 2001 and 2004 (p < 0.001) and by 42% in oncological diagnosis between 2002 and 2004 (p = 0.003). CONCLUSIONS: Our experience reveals that participation in external quality assessment programs has significant advantages, helping to standardize and to assure quality in cytogenetic testing.


Assuntos
Análise Citogenética/métodos , Análise Citogenética/normas , Testes Genéticos , Técnicas de Diagnóstico Molecular/métodos , Técnicas de Diagnóstico Molecular/normas , Neoplasias/diagnóstico , Garantia da Qualidade dos Cuidados de Saúde , Genótipo , Humanos , Itália , Neoplasias/genética , Diagnóstico Pré-Natal , Fatores de Tempo
11.
Ann Ig ; 20(6): 519-30, 2008.
Artigo em Italiano | MEDLINE | ID: mdl-19238877

RESUMO

In Italy at least 3% of babies are born with some congenital malformation. The intake of folic acid (FA) prior to conception and during the early stages of pregnancy plays an important role in preventing neural tube defects, severe anomalies of brain embryogenesis, and other malformations such as cardiac and urinary tract anomalies, oro-facial clefts and limb reduction defects. The Italian Network for Folic Acid Promotion, coordinated by the National Center on Rare Diseases of the Italian National Institute of Health, has elaborated and diffused a recommendation for the periconceptional FA supplementation: "Women of child-bearing age, are recommended to consume 0,4 mg/day of FA, to reduce the risk of congenital defects. The intake of folic acid should start at least one month before the conception and should continue for the first quarter of pregnancy". This paper discusses various strategies in order to promote FA intake during periconceptional period. Food fortification, adopted in several countries such as USA, has raised concerns about the risk of an excessive FA intake which may lead to adverse effect such as tumour promotion. Currently, periconceptional supplementation and healthy dietary habits promotion appear to be the most effective strategies.


Assuntos
Anormalidades Congênitas/prevenção & controle , Suplementos Nutricionais , Ácido Fólico/administração & dosagem , Cuidado Pré-Concepcional/métodos , Primeiro Trimestre da Gravidez , Saúde Pública , Complexo Vitamínico B/administração & dosagem , Anormalidades Cardiovasculares/prevenção & controle , Ensaios Clínicos como Assunto , Medicina Baseada em Evidências , Feminino , Humanos , Deformidades Congênitas dos Membros/prevenção & controle , Anormalidades Maxilofaciais/prevenção & controle , Defeitos do Tubo Neural/prevenção & controle , Guias de Prática Clínica como Assunto , Gravidez , Ensaios Clínicos Controlados Aleatórios como Assunto , Resultado do Tratamento , Anormalidades Urogenitais/prevenção & controle
12.
Eur J Med Genet ; 50(3): 176-87, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17395558

RESUMO

Genetic heterogeneity in Nijmegen breakage syndrome (NBS) is highlighted by patients showing clinical and cellular features of NBS but with no mutations in NBS1 and normal levels of nibrin. NBS is an autosomal recessive disorder, whose clinical cellular signs include growth and developmental defects, dysmorphic facies, immunodeficiency, cancer predisposition, chromosomal instability and radiosensitivity. NBS is caused by mutations in the NBS1 gene, whose product is part of the MRE11/RAD50/NBS1 complex involved in the DNA double-strand break (DSB) response pathway. Since the identification of the NBS1 gene, patients with NBS clinical signs, particularly severe congenital microcephaly, are screened for mutations in the NBS1 gene. Further analyses include X-ray-induced chromosome aberrations, telomere analysis, kinetics of DSBs repair, levels of a panel of proteins involved in the maintenance of genetic stability, radiation-induced phosphorylation of various substrates and cell cycle analysis. We describe a patient with a NBS clinical phenotype, chromosomal sensitivity to X-rays but without mutations in the whole NBS1 or in the Cernunnos gene. Enhanced response to irradiation was mediated neither by DSBs rejoining defects nor by the NBS/AT-dependent DNA-damage response pathway. Notably, we found that primary fibroblasts from this patient displayed telomere length alterations. Cross-talk between pathways controlling response to DSBs and those involved in maintaining telomeres has been shown in the present patient. Dissecting the cellular phenotype of radiosensitive NBS-like patients represents a useful tool for the research of new genes involved in the cellular response to DSBs.


Assuntos
Anormalidades Craniofaciais/genética , Microcefalia/genética , Síndrome de Quebra de Nijmegen/genética , Tolerância a Radiação/genética , Telômero/genética , Proteínas de Ciclo Celular/genética , Cromossomos Humanos/efeitos da radiação , Reparo do DNA/genética , Feminino , Humanos , Masculino , Síndrome de Quebra de Nijmegen/diagnóstico , Proteínas Nucleares/genética , Fenótipo , Telômero/ultraestrutura
13.
Ann Ig ; 19(5): 443-50, 2007.
Artigo em Italiano | MEDLINE | ID: mdl-18210774

RESUMO

Opinions of patients and relatives about their experiences with health and social services were assessed in a pilot study. The study was carried out in collaboration with two patients' Associations of Neurofibromatosis, "Neurofibromatosi--Onlus" and "LINFA--Onlus". An ad-hoc questionnaire was developed by the Italian National Centre of Rare Diseases and was sent to the Responsibles of the two aforementioned patients' Associations. The Responsibles distributed the questionnaire to their members by mail. The questionnaire investigated, using 5-level Likert scales, the following topics: quality and accessibility of health services (diagnostic exams, pharmacological therapies, rehabilitation, psychological support), quality and accessibility of social services (school, vocational training, health information, information on legal matters and rights). Finally, the questionnaire investigated also opinions about improvements of public health and social services in the last three years. Overall, 79 out 144 questionnaires were filled by patients or their relatives. The most frequent negative experiences concerned vocational training and both health and legal information. The most frequent positive opinions were reported for the human relationships with health professionals. This pilot study seems to point out a promising way to investigate systematically opinions of patients suffering from rare diseases and their relatives.


Assuntos
Acessibilidade aos Serviços de Saúde , Serviços de Saúde/normas , Neurofibromatose 1 , Satisfação do Paciente , Serviço Social/normas , Adolescente , Adulto , Criança , Pré-Escolar , Família , Grupos Focais , Humanos , Itália , Pessoa de Meia-Idade , Neurofibromatose 1/terapia , Educação de Pacientes como Assunto , Projetos Piloto , Inquéritos e Questionários , Educação Vocacional
14.
Ann Ig ; 19(2): 153-60, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17547220

RESUMO

People suffering from rare diseases, independently of the condition, often experience the same problems in receiving adequate health and social care. It is not clear how these problems differ in severity among different diseases and in different countries and how they change in time. In the framework of the NEPHIRD (Network of Public Health Institutions on Rare Diseases), a European project, funded by DG-SANCO (EU Commission), an effort was made to develop a simple but comprehensive tool to show patients' and/or caregivers' opinions about the quality and accessibility of health and social services. The self-filled questionnaire asks how often patients or caregivers had both negative and positive experiences about the quality and accessibility of health and social services and their opinion on their improvement, on 5-level scales. A pilot survey was carried out in several European Countries among members of Myasthenia Gravis, Neurofibromatosis, Prader Willi and Rett Syndrome volunteers' associations. Descriptive and comparative analyses were performed using Stata and Epi Info 2000. In total, 302 questionnaires were completed in France, Italy, Romania, Spain, Turkey and United Kingdom during 2004-05. In general, respondents thought that health care accessibility was worse than quality, and that social care and legal provisions were worse than health care, with some differences among countries. For all diseases, and for both patients and caregivers, the most frequent reported positive experiences were health professionals' kindness and readiness to help (all medians ranged from 3 to 5). As for the efforts for improvement made by public services in the last three years, the opinions were generally favourable. This study has several limitations. However the assessment tool that has been developed has some innovative and interesting features and may be considered a useful attempt to compare patients' and caregivers' experiences for a range of different diseases, countries and services, with respect to a rare disease programme.


Assuntos
Cuidadores , Acessibilidade aos Serviços de Saúde/estatística & dados numéricos , Satisfação do Paciente , Doenças Raras , Serviço Social/estatística & dados numéricos , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Cuidadores/estatística & dados numéricos , Criança , Pré-Escolar , Feminino , França , Acessibilidade aos Serviços de Saúde/normas , Humanos , Itália , Masculino , Pessoa de Meia-Idade , Satisfação do Paciente/estatística & dados numéricos , Projetos Piloto , Qualidade da Assistência à Saúde/estatística & dados numéricos , Romênia , Serviço Social/normas , Espanha , Inquéritos e Questionários , Turquia , Reino Unido
15.
Reprod Toxicol ; 22(1): 8-12, 2006 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-16530380

RESUMO

The aim of the study was to explore the role of environmental exposures to pesticides in the birth prevalence of hypospadias and cryptorchidism, in the 12 agricultural municipalities of Ragusa Sicily. Data on the birth prevalence of the two birth defects were obtained from the local pediatric services for the period 1998-2002. Municipalities were ranked according to the degree of "pesticide impact" on the basis of three quantitative criteria of intensity of agricultural activities of the population. We found a significantly higher birth prevalence of hypospadias with increasing "pesticide impact" (trend test, P=0.003). The association with cryptorchidism was not statistically significant, but when the two birth defects were pooled together, the linear trend was significant (trend test, P=0.001).


Assuntos
Criptorquidismo/epidemiologia , Hipospadia/epidemiologia , Praguicidas/intoxicação , Anormalidades Múltiplas/epidemiologia , Criança , Criptorquidismo/induzido quimicamente , Exposição Ambiental/estatística & dados numéricos , Feminino , Humanos , Hipospadia/induzido quimicamente , Nascido Vivo/epidemiologia , Masculino , Exposição Materna/estatística & dados numéricos , Gravidez , Sistema de Registros/estatística & dados numéricos , Estudos Retrospectivos , Sicília/epidemiologia
17.
Eur J Health Econ ; 17 Suppl 1: 79-87, 2016 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-27086322

RESUMO

OBJECTIVE: The aim of this study was to determine the economic burden from a societal perspective and the health-related quality of life (HRQOL) of patients with juvenile idiopathic arthritis (JIA) in Europe. METHODS: We conducted a cross-sectional study of patients with JIA from Germany, Italy, Spain, France, the United Kingdom, Bulgaria, and Sweden. Data on demographic characteristics, healthcare resource utilization, informal care, labor productivity losses, and HRQOL were collected from the questionnaires completed by patients or their caregivers. HRQOL was measured with the EuroQol 5-domain (EQ-5D-5L) questionnaire. RESULTS: A total of 162 patients (67 Germany, 34 Sweden, 33 Italy, 23 United Kingdom, 4 France, and 1 Bulgaria) completed the questionnaire. Excluding Bulgarian results, due to small sample size, country-specific annual health care costs ranged from €18,913 to €36,396 (reference year: 2012). Estimated direct healthcare costs ranged from €11,068 to €22,138; direct non-healthcare costs ranged from €7837 to €14,155 and labor productivity losses ranged from €0 to €8715. Costs are also shown to differ between children and adults. The mean EQ-5D index score for JIA patients was estimated at between 0.44 and 0.88, and the mean EQ-5D visual analogue scale score was estimated at between 62 and 79. CONCLUSIONS: JIA patients incur considerable societal costs and experience substantial deterioration in HRQOL in some countries. Compared with previous studies, our results show a remarkable increase in annual healthcare costs for JIA patients. Reasons for the increase are the inclusion of non-professional caregiver costs, a wider use of biologics, and longer hospital stays.


Assuntos
Artrite Juvenil/economia , Efeitos Psicossociais da Doença , Custos de Cuidados de Saúde , Qualidade de Vida , Adolescente , Adulto , Artrite Juvenil/psicologia , Cuidadores , Criança , Pré-Escolar , Estudos Transversais , Europa (Continente) , Feminino , Custos de Cuidados de Saúde/estatística & dados numéricos , Humanos , Masculino , Pessoa de Meia-Idade , Assistência ao Paciente/economia , Licença Médica/economia , Perfil de Impacto da Doença , Fatores Socioeconômicos , Inquéritos e Questionários , Reino Unido , Adulto Jovem
18.
Ann Ig ; 17(2): 121-8, 2005.
Artigo em Italiano | MEDLINE | ID: mdl-16676732

RESUMO

This paper concerns the first phase of a study about the perception of social and health needs of people with rare diseases. The study was performed by the National Center for Rare Diseases at the Italian National Institute of Health (Istituto Superiore di Sanità - ISS). The project wants to be an example of collaboration between the research and the association worlds. Responsible of Associations of Patients and their relatives were asked their opinion about the accessibility and quality of important features of health and social services (accessibility and quality of diagnostic, pharmacological, psychological and rehabilitative interventions, social support, school and vocational training, information that was given to relatives). An ad hoc questionnaire was developed through focus groups. The questionnaire was completed by 108 associations (26,5% of the associations thar are recorded in the ISS database). Average scores showed satisfaction only for some variables and a negative gradient north-south was observed. The most frequent complaints were about information, quality of school and job training services and availability of psychological support. The study showed an high level of dissatisfaction with availability, quality and integration health and social services.


Assuntos
Pesquisa Biomédica , Acessibilidade aos Serviços de Saúde/estatística & dados numéricos , Doenças Raras , Serviço Social/estatística & dados numéricos , Instituições Filantrópicas de Saúde , Academias e Institutos , Comportamento Cooperativo , Acessibilidade aos Serviços de Saúde/normas , Humanos , Itália , Organizações sem Fins Lucrativos , Satisfação do Paciente/estatística & dados numéricos , Projetos Piloto , Serviço Social/normas , Sociedades , Inquéritos e Questionários
19.
J Clin Endocrinol Metab ; 87(2): 557-62, 2002 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11836285

RESUMO

In the last decade a high frequency of other congenital anomalies has been reported in infants with congenital hypothyroidism (CH) detected by neonatal screening. In the present study the occurrence of additional congenital malformations (CM) in the population of CH infants detected in Italy between 1991 and 1998 (n = 1420) was investigated. In Italy all of the centers in charge of screening, treatment, and follow-up of CH adhere to the Italian National Registry of infants with CH. In this study a high prevalence of additional CM (8.4%), more than 4-fold higher than that reported in the Italian population (1-2%), was found in the population of CH infants. Cardiac anomalies represented the most frequent malformations associated with CH, with a prevalence of 5.5%. However, a significant association between CH and anomalies of nervous system, eyes, and multiple CM was also observed. In conclusion, the significantly higher frequency of extrathyroidal congenital malformations reported in the CH infants than in the general population represents a further argument supporting the role of a genetic component in the etiology of CH. Investigations of the molecular mechanisms underlying developmental events of formation of thyroid and other organs represent critical steps in the knowledge of CH etiology.


Assuntos
Anormalidades Congênitas/epidemiologia , Hipotireoidismo Congênito , Hipotireoidismo/complicações , Anormalidades Múltiplas/epidemiologia , Anormalidades do Olho/complicações , Anormalidades do Olho/epidemiologia , Feminino , Humanos , Incidência , Lactente , Recém-Nascido , Itália , Masculino , Triagem Neonatal/normas , Malformações do Sistema Nervoso/complicações , Malformações do Sistema Nervoso/epidemiologia , Prevalência , Sistema de Registros
20.
Gene ; 109(2): 211-8, 1991 Dec 30.
Artigo em Inglês | MEDLINE | ID: mdl-1765268

RESUMO

Molecular cloning studies have now identified five structurally homologous genes encoding the biosynthesis of the human dopamine receptors, DRD1, DRD2, DRD3, DRD4, and DRD5. Two of these dopamine receptors (DRD1 and DRD5) are encoded by intronless genes. To ascertain whether there are other intronless genes that share identity with the gene (DRD5) encoding the DRD5 receptor, we used a cloning method based on the polymerase chain reaction (PCR). Human genomic DNA was amplified by PCR with oligodeoxyribonucleotides (oligos) based on the DRD5 nucleotide (nt) sequence. Amplification of nt sequences between these oligos allowed the isolation of two independent intronless genes that share identity with DRD5. The full-length clones have also been isolated by screening human genomic libraries. The deduced amino acid sequences for these genes, PG-1 and PG-2, share 91% and 92% identity to DRD5, respectively. However, each of the genes contains differences in the coding regions that would render these genes incapable of encoding functional receptors. Thus, the human genome contains at least two DRD5 pseudogenes, consistent with in situ human chromosomal hybridization analysis which reveals the presence of two pseudogenes.


Assuntos
Família Multigênica/genética , Pseudogenes/genética , Receptores de Dopamina D1 , Receptores Dopaminérgicos/genética , Sequência de Aminoácidos , Sequência de Bases , Southern Blotting , Cromossomos Humanos Par 1 , Cromossomos Humanos Par 2 , Cromossomos Humanos Par 4 , Clonagem Molecular , Códon/genética , Humanos , Íntrons/genética , Dados de Sequência Molecular , Hibridização de Ácido Nucleico , Oligodesoxirribonucleotídeos/genética , Reação em Cadeia da Polimerase , Receptores de Dopamina D5 , Homologia de Sequência do Ácido Nucleico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA